Yenis V. Argueta Guevara of Ropes & Gray has filed for drug developer Protection Bio and its top executives in pending securities class action. The lawsuit alleging defendants’ misleading investors regarding the likelihood of FDA approval of their diabetes drug teplizumab was filed in New Jersey District Court on May 21 by Pomerantz LLP and Bronstein, Gewirtz & Grossman. The case assigned to U.S. District Judge Michael A. Shipp is 3: 21-cv-11613, Paxton v. Provention Bio, Inc. et al.
This lawsuit was exposed by Law.com Radar, a source of quick legal news and litigation tailored to your practice. Law.com Radar publishes daily updates on federal cases just filed like this one. Click here to get started and be the first to find out about new suits in your region, your area of activity or your customer area
